Chemotaxis of human basophil leucocytes
Kay, A.B.; Austen, K.F.
Clinical and Experimental Immunology 11(4): 557-563
1972
ISSN/ISBN: 0009-9104 PMID: 4507993 Document Number: 49662
Document emailed within 1 workday
Related Documents
Boseila, A.W.; Shoukry, A.S.; Mohareb, S.W. 1971: Basophil leucocytes in ascariasis Journal of the Egyptian Medical Association 54(8): 512-514Snyderman, R. 1974: Mediators of the chemotaxis of mononuclear leucocytes Nouvelle Revue Francaise d'Hematologie 13(6): 888-889
MacGlashan, D.W.; Peters, S.P.; Warner, J.; Lichtenstein, L.M. 1986: Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links Journal of Immunology 136(6): 2231-2239
Nelson, R.D.; Quie, P.G.; Simmons, R.L. 1975: Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes Journal of Immunology 115(6): 1650-1656
Frei, P.C.; Hermanovicz, A.; Pécoud, A. 1978: Chemotaxis of human polymorphonuclears in vitro. V. Role of the nonsegmented neutrophils and of the experimental conditions in the impairment of chemotaxis observed during bacterial infections Journal of Laboratory and Clinical Medicine 92(4): 577-584
Trippestad, A.; Midtvedt, T. 1971: Chemotaxis of polymorphonuclear leucocytes from germ-free rats and generation of chemotactic activity in germ-free rat sera Clinical and Experimental Immunology 8(4): 639-646
Yeaman, G.R.; Kerr, M.A. 1987: Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes Clinical and Experimental Immunology 68(1): 200-208
Hastie, R. 1974: A study of the ultrastructure of human basophil leukocytes Laboratory Investigation; a Journal of Technical Methods and Pathology 31(3): 223-231
Petiot, J.F.; Sainte-Laudy, J.; Benveniste, J. 1981: Interpretation of results on a human basophil degranulation test Annales de Biologie Clinique 39(6): 355-359
Vuitton, D.; Lenys, D.; Flausse, F.; Bresson, S.; Barale, T.; Liance, M.; Wattre, P.; Miguet, J.P. 1985: Circulating and basophil-fixed specific IgE in human alveolar echinococcosis Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 179(6): 782-787
Shen, H.H.; Liu, F.G.; Hu, Y.M. 1991: Clinical significance of human basophil releasability in bronchial asthma Zhonghua Nei Ke Za Zhi 30(9): 539
Orchard, M.A.; Kagey-Sobotka, A.; Proud, D.; Lichtenstein, L.M. 1986: Basophil histamine release induced by a substance from stimulated human platelets Journal of Immunology 136(6): 2240-2244
Hirai, K.; Morita, Y.; Misaki, Y.; Ohta, K.; Takaishi, T.; Suzuki, S.; Motoyoshi, K.; Miyamoto, T. 1988: Modulation of human basophil histamine release by hemopoietic growth factors Journal of Immunology 141(11): 3958-3964
Hirai, K.; Miyamasu, M.; Yamaguchi, M.; Nakajima, K.; Ohtoshi, T.; Koshino, T.; Takaishi, T.; Morita, Y.; Ito, K. 1993: Modulation of human basophil histamine release by insulin-like growth factors Journal of Immunology 150(4): 1503-1508
Kelényi, G.; Németh, A. 1972: Tissue eosinophil leucocytes. II. Electron microscopy and histochemistry of the uterine eosinophil leucocytes in oestrogen-treated spayed rats Acta Biologica Academiae Scientiarum Hungaricae 23(3): 253-267
Källén, B.; Löw, B.; Nilsson, O. 1977: Confounding factors in HLA-DW 2 typing of human leucocytes Clinical and Experimental Immunology 27(1): 55-62
Laufen, H.; Wildfeuer, A.; Lach, P. 1990: Mechanism of azithromycin uptake in human polymorphonuclear leucocytes Arzneimittel-Forschung 40(6): 686-689
Yamada, T.; Tabata, Y.; Ariga, T.; Tsuji, S.; Miyatake, T. 1982: Studies on sialidoses: GM3 ganglioside sialidase in human leucocytes Advances in Experimental Medicine and Biology 152: 261-272
Kemp, A.S.; Cripps, A.W.; Brown, S. 1980: Suppression of leucocyte chemokinesis and chemotaxis by human IgA Clinical and Experimental Immunology 40(2): 388-395
Laufen, H.; Wildfeuer, A. 1989: Kinetics of the uptake of antimicrobial agents by human polymorphonuclear leucocytes Arzneimittel-Forschung 39(2): 233-235